USPTO serial 97409044
CROWN BIOSCIENCE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Sep 22, 2026
- Examiner
- COWARD, JEFFERY
- Law office
- INTENT TO USE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with CROWN BIOSCIENCE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Yi Zhang
20380 TOWN CENTER LANE, SUITE 128CUPERTINO, CA 95014United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable computer application software for mobile phones, namely, software for searching genomic data, pharmaceutical data, histological data, xenograft data, human cell line data, derived xenografts data, homografts of mouse tumor models data, mouse cell line data, syngeneic models data, and other animal models, specifically, mice and monkeys data; Downloadable computer software for searching genomic data, pharmaceutical data, histological data, xenograft data, human cell line data, derived xenografts data, homografts of mouse tumor models data, mouse cell line data, syngeneic models data, and other animal models, specifically, mice and monkeys data; Downloadable mobile applications for searching genomic data, pharmaceutical data, histological data, xenograft data, human cell line data, derived xenografts data, homografts of mouse tumor models data, mouse cell line data, syngeneic models data, and other animal models, specifically, mice and monkeys data; Downloadable software in the nature of a mobile application for searching genomic data, pharmaceutical data, histological data, xenograft data, human cell line data, derived xenografts data, homografts of mouse tumor models data, mouse cell line data, syngeneic models data, and other animal models, specifically, mice and monkeys data | ACTIVE | Oct 25, 2021 |
| 042 | Consulting services in the field of biotechnology; Laboratory research services relating to pharmaceuticals; Medical and scientific research in the field of cancer treatment and diagnosis; Medical laboratory services; Medical research services in the field of cancer; Pharmaceutical drug development services; Providing a members-only website featuring technology which provides members with the ability to search genomic data, pharmaceutical data, histological data, xenograft data, human cell line data, derived xenografts data, homografts of mouse tumor models data, mouse cell line data, syngeneic models data, and other animal models, specifically, mice and monkeys data; Providing a secured-access, members only website featuring technology that gives members the ability to search genomic data, pharmaceutical data, histological data, xenograft data, human cell line data, derived xenografts data, homografts of mouse tumor models data, mouse cell line data, syngeneic models data, and other animal models, specifically, mice and monkeys data; Providing a web site featuring technology that enables users to search genomic data, pharmaceutical data, histological data, xenograft data, human cell line data, derived xenografts data, homografts of mouse tumor models data, mouse cell line data, syngeneic models data, and other animal models, specifically, mice and monkeys data; Providing a website featuring non-downloadable software for searching genomic data, pharmaceutical data, histological data, xenograft data, human cell line data, derived xenografts data, homografts of mouse tumor models data, mouse cell line data, syngeneic models data, and other animal models, specifically, mice and monkeys data; Providing a website featuring on-line non-downloadable software that enables users to search genomic data, pharmaceutical data, histological data, xenograft data, human cell line data, derived xenografts data, homografts of mouse tumor models data, mouse cell line data, syngeneic models data, and other animal models, specifically, mice and monkeys data; Providing a website featuring resources, namely, non-downloadable software for searching genomic data, pharmaceutical data, histological data, xenograft data, human cell line data, derived xenografts data, homografts of mouse tumor models data, mouse cell line data, syngeneic models data, and other animal models, specifically, mice and monkeys data; Providing reagent sample testing and diagnostic services for others for scientific research purposes; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research and development of vaccines and medicines; Scientific and technological services, namely, analyzing preclinical oncology efficacy in the field of medical treatment; Scientific laboratory services; Scientific research for medical purposes in the area of cancerous diseases; Technical research in the field of pharmaceutical studies | ACTIVE | Oct 25, 2021 |
| 044 | Drug use screening services; Drug use testing services; Drug, alcohol and DNA screening for medical purposes; Medical screening; Medical services, namely, pre-employment drug screening; Providing information in the field of cancer prevention, screening, diagnosis and treatment | ACTIVE | Oct 25, 2021 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Crown Bioscience, Inc.
- Other trademarks owned by Crown Bioscience, Inc.
- Other trademarks owned by Crown Bioscience, Inc.
- Other trademarks in Class 009
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named CROWN BIOSCIENCE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 22, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Sep 22, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 3, 2026 | DP1B | 1(B) BASIS DELETED; PROCEED TO REGISTRATION | — |
| Aug 5, 2026 | IUCN | NOTICE OF ALLOWANCE CANCELLED | — |
| Aug 5, 2026 | EPPA | TEAS POST PUBLICATION AMENDMENT RECEIVED | — |
| Feb 17, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Feb 17, 2026 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Feb 6, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 5, 2026 | EXT4 | SOU EXTENSION 4 FILED | — |
| Sep 30, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Sep 29, 2025 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Sep 11, 2025 | TPEX | SOU EXTENSION RECEIVED WITH TEAS PETITION | — |
| Sep 11, 2025 | NREV | NOTICE OF REVIVAL - E-MAILED | — |
| Sep 11, 2025 | PETG | PETITION TO REVIVE-GRANTED | — |
| Sep 11, 2025 | PROA | TEAS PETITION TO REVIVE RECEIVED | — |
| Sep 8, 2025 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Sep 8, 2025 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Aug 5, 2025 | EXT3 | SOU EXTENSION 3 FILED | — |
| Feb 6, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Feb 6, 2025 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Feb 6, 2025 | EXT2 | SOU EXTENSION 2 FILED | — |
| Feb 5, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 3, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Dec 3, 2024 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Dec 2, 2024 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Sep 9, 2024 | TPEX | SOU EXTENSION RECEIVED WITH TEAS PETITION | — |
| Sep 9, 2024 | NREV | NOTICE OF REVIVAL - E-MAILED | — |
| Sep 9, 2024 | PETG | PETITION TO REVIVE-GRANTED | — |
| Sep 9, 2024 | PROA | TEAS PETITION TO REVIVE RECEIVED | — |
| Sep 9, 2024 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Sep 9, 2024 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Aug 6, 2024 | EXT1 | SOU EXTENSION 1 FILED | — |
| Feb 6, 2024 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Dec 12, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 12, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 22, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 7, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 7, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 7, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 7, 2023 | ALIE | ASSIGNED TO LIE | — |
| Jun 5, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 6, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 6, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 6, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 2, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| May 19, 2022 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| May 18, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 17, 2022 | NWAP | NEW APPLICATION ENTERED | — |